The variants of genes like PPARG, ADIPOQ, and ENPP1 which act at the level of insulin resistance have been shown to increase the risk of T2DM only in obese populations [39–41] and hence it has been suggested that T2DM risk contribution of gene polymorphism may be modulated by obesity status. Here, ADIPOQ is linked to obesity disorder.